ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Cold Atmospheric Plasma-Activated In Situ Hydrogel Induces Hair Regeneration Via Immune Microenvironment Remodeling.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hair follicle organoids: advances in construction, applications, and translational challenges.Frontiers in cell and developmental biology · 2026Review
- Cold Atmospheric Plasma-Activated In Situ Hydrogel Induces Hair Regeneration Via Immune Microenvironment Remodeling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Hair loss is a prevalent condition with limited effective treatments. Here, a cold atmospheric plasma (CAP)-activated in situ hydrogel is reported, which modulates the hair follicle immune microenvironment and promotes hair regeneration. CAP irradiation induces the gelation of a tyramine-grafted hyaluronic acid solution containing interleukin-2 (HTsol/IL2), forming a hydrogel (CAPgel/IL2) that retains CAP-induced reactive oxygen species and IL2 within its matrix. In vivo, subcutaneous injection of HTsol/IL2 into the dorsal skin of mice, followed by CAP exposure at the injection site, induces in situ formation of CAPgel/IL2. In a depilated mouse model, CAPgel/IL2 treatment results in significantly greater hair regeneration than other groups, characterized by enlarged hair follicles and a thickened hypodermis. The prolonged retention of IL2 in CAPgel/IL2 leads to an increased expansion of Treg within the hair follicle microenvironment. Additionally, CAPgel/IL2-treated mice exhibit accelerated skin pigmentation changes, indicating a transition from the telogen to the anagen phase. These findings suggest that CAPgel/IL2 enhances regulatory T cell expansion in the hair follicle microenvironment and may serve as a potential treatment for hair loss. Moreover, the CAP-activated IL2 delivery strategy, which modulates skin immune responses, may be extended to other immunologic skin disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.